Surgenex® is committed to turning innovative scientific research into industry leading human cellular and tissue-based products.
The patented Excellion® process is used to produce the highest quality allograft tissues using tightly controlled surgical procedures.
Surgenex® prides itself on exceeding regulatory safety standards through rigorous quality processes and third-party serological testing.
With unprecedented service and care for providers and their patients our staff is dedicated to providing the very best at a competitive price.
Dehydrated, terminally irradiated membranes available in multiple configurations and sizes
Learn MoreOrthobiologic allografts processed to preserve the native biomechanical structure of the tissue
Learn MoreDecellularized and processed to preserve the biological properties that promote revascularization and repair
Learn MorePrecision milled structural allografts to support spinal and foot & ankle surgery
Learn MoreCustom analytical development for characterization and lot release testing
Learn MoreAll tissue goes through extensive donor screening and is solely procured by FDA registered tissue banks.
Through tightly controlled surgical procedures the tissue is cleaned, processed, and stored to maximize its therapeutic benefits.
Each product is carefully inspected by our Quality Assurance Team and stored in a controlled and monitored environment to ensure quality and longevity.
Mr. Diaz has over 30 years of sales, commercial operations and executive leadership experience in the biologics and medical device industries. He has worked at both public and private companies including Matria Healthcare, MiMedx and BioIQ.
Through his career, Mr. Diaz has led negotiations on multi-year, multimillion-dollar contracts with GPOs and IDNs and many Fortune 500 companies. He obtained a Master of International Management from Schiller International University, a Bachelor of Science in International Affairs from Florida State University and is a Six Sigma Green Belt. He lived in Europe for 16 years and speaks German.
Mr. Robinson has nearly two decades of Private Equity and Venture Capital experience in CFO and Controller roles including previous experience working with tissue banks.
Mr. Robinson has worked closely with many entrepreneurs through rapid growth cycles and M&A transaction. Mr. Robinson has a BS of Accounting and Business Management, and an MBA degree. He is also a Certified Valuation Analyst (CVA), and a Certified Merger and Acquisition Advisor (CM&AA).
Ms. Warn, recognized for her strategic leadership, boasts nearly three decades of experience in quality, regulatory, and performance excellence across various sectors including biotechnology, tissue banking, hospitals, and laboratories. Her expertise lies in developing and spearheading enterprise-wide regulatory affairs and quality management systems, ensuring rigorous adherence to the highest regulatory standards while driving operational process enhancements.
Ms. Warn actively contributes to the field by serving on various committees and councils within the American Association of Tissue Banks.. Her educational background includes an MBA, a BS in Business Administration, and an AAS in Medical Laboratory Technology. Additionally, she is certified by the American Society of Quality (CMQOE) and the American Society of Clinical Pathologists (MLT).
